SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-144950
Filing Date
2021-04-30
Accepted
2021-04-30 16:02:52
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d176439ddef14a.htm DEF 14A 444555
2 GRAPHIC g176439g45t78.jpg GRAPHIC 46043
3 GRAPHIC g176439t3.jpg GRAPHIC 88683
4 GRAPHIC g176439t4.jpg GRAPHIC 110451
  Complete submission text file 0001193125-21-144950.txt   776650
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38443 | Film No.: 21877713
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences